TAP Consulting’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,791
Closed -$239K 154
2024
Q3
$239K Buy
1,791
+66
+4% +$8.5K 0.05% 144
2024
Q2
$201K Buy
+1,725
New +$194K 0.04% 154
2022
Q1
Sell
-1,184
Closed -$172K 229
2021
Q4
$172K Buy
+1,184
New +$144K 0.04% 145

Other funds holding CURE

TAP Consulting's CURE Position: Q4 2024 in Review

TAP Consulting sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q4 2024, closing a stake of 1,791 shares — an estimated $239K sold.

TAP Consulting first reported a position in CURE in Q4 2021 and held it in 3 quarters. The position peaked at $239K in Q3 2024. 23 funds tracked by Wall St. Rank hold CURE as of Q4 2024.

  • TAP Consulting reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
  • TAP Consulting sold 1,791 Direxion Daily Healthcare Bull 3X ETF shares in Q4 2024, an estimated $239K.
  • TAP Consulting first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q4 2021 and held it in 3 quarters.
  • TAP Consulting's Direxion Daily Healthcare Bull 3X ETF position peaked at $239K in Q3 2024.
  • 23 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q4 2024.

Based on TAP Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.